Praxis Precision Medicines (PRAX) Profit After Tax (2022 - 2025)
Historic Profit After Tax for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$73.9 million.
- Praxis Precision Medicines' Profit After Tax fell 4242.73% to -$73.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$273.0 million, marking a year-over-year decrease of 8079.96%. This contributed to the annual value of -$182.8 million for FY2024, which is 4829.94% down from last year.
- Latest data reveals that Praxis Precision Medicines reported Profit After Tax of -$73.9 million as of Q3 2025, which was down 4242.73% from -$71.1 million recorded in Q2 2025.
- Praxis Precision Medicines' Profit After Tax's 5-year high stood at -$24.6 million during Q3 2023, with a 5-year trough of -$73.9 million in Q3 2025.
- For the 4-year period, Praxis Precision Medicines' Profit After Tax averaged around -$49.0 million, with its median value being -$43.9 million (2022).
- Its Profit After Tax has fluctuated over the past 5 years, first soared by 4549.38% in 2023, then tumbled by 11831.61% in 2024.
- Praxis Precision Medicines' Profit After Tax (Quarter) stood at -$41.2 million in 2022, then skyrocketed by 34.72% to -$26.9 million in 2023, then tumbled by 118.32% to -$58.7 million in 2024, then decreased by 26.0% to -$73.9 million in 2025.
- Its last three reported values are -$73.9 million in Q3 2025, -$71.1 million for Q2 2025, and -$69.3 million during Q1 2025.